cytosine has been researched along with Skin Diseases, Viral in 13 studies
Skin Diseases, Viral: Skin diseases caused by viruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acyclovir-resistant herpes simplex virus (HSV) infection is common in immunocompromised patients, but the course of such infection is little known." | 7.80 | Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. ( Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D, 2014) |
| " One patient with AIDS suffered from a perineal lesion due to infection with herpes simplex virus type 2 (HSV-2) and did not respond to acyclovir and was intolerant of foscarnet." | 7.69 | Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). ( Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G, 1994) |
| "Acyclovir-resistant herpes simplex virus (HSV) infection is common in immunocompromised patients, but the course of such infection is little known." | 3.80 | Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. ( Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D, 2014) |
| " One patient with AIDS suffered from a perineal lesion due to infection with herpes simplex virus type 2 (HSV-2) and did not respond to acyclovir and was intolerant of foscarnet." | 3.69 | Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). ( Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G, 1994) |
| "No recurrence was observed in nine patients over an average follow-up period of 24." | 2.69 | Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. ( Calista, D, 2000) |
| "Giant molluscum contagiosum is a clinical variant in which large nodule greater than 0." | 2.50 | Cutaneous viral infections in organ transplant patients. ( Alaibac, M; Peserico, A; Piaserico, S; Sandini, E, 2014) |
| "Human papillomavirus infection is one of the most common and most distressing cutaneous diseases in patients with HIV infection." | 1.33 | Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. ( Kottke, MD; Parker, SR, 2006) |
| "Anogenital condylomata acuminata are the most frequent clinical manifestation of genital human papillomavirus (HPV) infection." | 1.31 | Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection. ( Farese, A; Giorgini, S; Martinelli, C; Mistro, AD; Ruffino, I, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seang, S | 1 |
| Boutolleau, D | 1 |
| Burrel, S | 1 |
| Regnier, S | 1 |
| Epelboin, L | 1 |
| Voujon, D | 1 |
| Valantin, MA | 1 |
| Katlama, C | 1 |
| Agut, H | 1 |
| Caumes, E | 1 |
| Piaserico, S | 1 |
| Sandini, E | 1 |
| Peserico, A | 1 |
| Alaibac, M | 1 |
| Pi Sala, N | 1 |
| Figueras Suriol, A | 1 |
| Ramió Montero, E | 1 |
| Smee, DF | 1 |
| Bailey, KW | 1 |
| Wong, MH | 1 |
| Tarbet, EB | 1 |
| Toutous-Trellu, L | 1 |
| Hirschel, B | 1 |
| Piguet, V | 1 |
| Schiffer, V | 1 |
| Saurat, JH | 1 |
| Pechère, M | 1 |
| Tan, HH | 1 |
| Goh, CL | 1 |
| Kottke, MD | 1 |
| Parker, SR | 1 |
| Snoeck, R | 1 |
| Andrei, G | 1 |
| Gérard, M | 1 |
| Silverman, A | 1 |
| Hedderman, A | 1 |
| Balzarini, J | 1 |
| Sadzot-Delvaux, C | 1 |
| Tricot, G | 1 |
| Clumeck, N | 1 |
| De Clercq, E | 1 |
| Zabawski, EJ | 2 |
| Cockerell, CJ | 1 |
| Afouna, MI | 1 |
| Mehta, SC | 1 |
| Ghanem, AH | 1 |
| Higuchi, WI | 1 |
| Kern, ER | 1 |
| DeClercq, E | 1 |
| El-Shattawy, HH | 1 |
| Calista, D | 1 |
| Martinelli, C | 1 |
| Farese, A | 1 |
| Mistro, AD | 1 |
| Giorgini, S | 1 |
| Ruffino, I | 1 |
4 reviews available for cytosine and Skin Diseases, Viral
| Article | Year |
|---|---|
Cutaneous viral infections in organ transplant patients.
Topics: Acitretin; Administration, Cutaneous; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Dermat | 2014 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad | 2006 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; | 1998 |
A review of topical and intralesional cidofovir.
Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; DNA Virus Infections; DNA V | 2000 |
2 trials available for cytosine and Skin Diseases, Viral
| Article | Year |
|---|---|
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Herpes Simplex; HIV I | 2004 |
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; C | 2000 |
7 other studies available for cytosine and Skin Diseases, Viral
| Article | Year |
|---|---|
Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug | 2014 |
[Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
Topics: Antiviral Agents; Cidofovir; Cytosine; Fingers; Humans; Infusions, Intralesional; Male; Middle Aged; | 2017 |
Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.
Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cyclophosphamide; Cytosine; Female; I | 2011 |
Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intravenous; Male; Organophosphona | 2006 |
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; | 1994 |
Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Topics: Acyclovir; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Female; Herpes S | 1999 |
Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; | 2001 |